Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

MacRae F Linton

Showing results (1-10 of 208) with videos related to

Pageof 21
Sort By:
Journal of Clinical Lipidology|December 3, 2010
High-density lipoprotein therapeutics and cardiovascular preventionSergio Fazio, Macrae F Linton
Current Opinion in Lipidology|September 28, 2002
Cyclooxygenase-2 and atherosclerosisMacRae F Linton, Sergio Fazio
Current Opinion in Pharmacology|April 6, 2004
Cyclooxygenase-2 and inflammation in atherosclerosisMacRae F Linton, Sergio Fazio
The Journal of Clinical Endocrinology and Metabolism|September 9, 2006
Sorting out the complexities of reverse cholesterol transport: CETP polymorphisms, HDL, and coronary diseaseSergio Fazio, MacRae F Linton
Journal of the American College of Cardiology|May 5, 2012
Proprotein convertase subtilisin/kexin type 9 as transducer of physiologic influences on cellular cholesterol: a case for resistinSergio Fazio, MacRae F Linton
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2010
6-Mercaptopurine, monocytes, and atherosclerosisMacrae F Linton, Sergio Fazio
Molecular Interventions|March 3, 2004
Apolipoprotein AI as therapy for atherosclerosis: does the future of preventive cardiology include weekly injections of the HDL protein?Sergio Fazio, MacRae F Linton
Journal of the American Society of Nephrology : JASN|August 31, 2015
HDL: Beyond AtheroprotectionValentina Kon, MacRae F Linton
Lancet (London, England)|May 26, 2009
Fenofibrate and risk of minor amputations in diabetesSergio Fazio, MacRae F Linton
Current Opinion in Lipidology|July 11, 2007
A new age of discovery for plasma lipoproteinsSergio Fazio, MacRae F Linton
Pageof 21

Showing results (1-10 of 208) with videos related to

Sort By:
Pageof 21
Journal of Clinical Lipidology|December 3, 2010
High-density lipoprotein therapeutics and cardiovascular preventionSergio Fazio, Macrae F Linton
Current Opinion in Lipidology|September 28, 2002
Cyclooxygenase-2 and atherosclerosisMacRae F Linton, Sergio Fazio
Current Opinion in Pharmacology|April 6, 2004
Cyclooxygenase-2 and inflammation in atherosclerosisMacRae F Linton, Sergio Fazio
The Journal of Clinical Endocrinology and Metabolism|September 9, 2006
Sorting out the complexities of reverse cholesterol transport: CETP polymorphisms, HDL, and coronary diseaseSergio Fazio, MacRae F Linton
Journal of the American College of Cardiology|May 5, 2012
Proprotein convertase subtilisin/kexin type 9 as transducer of physiologic influences on cellular cholesterol: a case for resistinSergio Fazio, MacRae F Linton
Arteriosclerosis, Thrombosis, and Vascular Biology|July 16, 2010
6-Mercaptopurine, monocytes, and atherosclerosisMacrae F Linton, Sergio Fazio
Molecular Interventions|March 3, 2004
Apolipoprotein AI as therapy for atherosclerosis: does the future of preventive cardiology include weekly injections of the HDL protein?Sergio Fazio, MacRae F Linton
Journal of the American Society of Nephrology : JASN|August 31, 2015
HDL: Beyond AtheroprotectionValentina Kon, MacRae F Linton
Lancet (London, England)|May 26, 2009
Fenofibrate and risk of minor amputations in diabetesSergio Fazio, MacRae F Linton
Current Opinion in Lipidology|July 11, 2007
A new age of discovery for plasma lipoproteinsSergio Fazio, MacRae F Linton
Pageof 21